These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 22331691)
1. The efficacy of in-and-out catheterization as a way of trial without catheterization strategy for treatment of acute urinary retention induced by benign prostate hyperplasia: variables predicting success outcome. Ko YH; Kim JW; Kang SG; Jang HA; Kang SH; Park HS; Moon du G; Cheon J; Kim JJ; Lee JG Neurourol Urodyn; 2012 Apr; 31(4):460-4. PubMed ID: 22331691 [TBL] [Abstract][Full Text] [Related]
2. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia. Desgrandchamps F; De La Taille A; Doublet JD; BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763 [TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia. Zhengyong Y; Changxiao H; Shibing Y; Caiwen W Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345 [TBL] [Abstract][Full Text] [Related]
4. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia. Bhomi KK; Bhattachan CL Nepal Med Coll J; 2011 Sep; 13(3):178-81. PubMed ID: 22808810 [TBL] [Abstract][Full Text] [Related]
5. The Reten-World survey of the management of acute urinary retention: preliminary results. Emberton M; Fitzpatrick JM BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683 [TBL] [Abstract][Full Text] [Related]
6. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia. Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358 [TBL] [Abstract][Full Text] [Related]
7. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K; BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624 [TBL] [Abstract][Full Text] [Related]
8. Management outcome of acute urinary retention: model of prediction. Daly P; Connolly S; Rogers E; Sweeney P Urol Int; 2009; 83(1):39-43. PubMed ID: 19641357 [TBL] [Abstract][Full Text] [Related]
9. Prostate size influences the outcome after presenting with acute urinary retention. McNeill AS; Rizvi S; Byrne DJ BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112 [TBL] [Abstract][Full Text] [Related]
10. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction. Alan McNeill S Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678 [TBL] [Abstract][Full Text] [Related]
11. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study. McNeill SA; Hargreave TB; Roehrborn CG; Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868 [TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial comparing transurethral prostatic resection and clean intermittent self-catheterization in men with chronic urinary retention. Ghalayini IF; Al-Ghazo MA; Pickard RS BJU Int; 2005 Jul; 96(1):93-7. PubMed ID: 15963128 [TBL] [Abstract][Full Text] [Related]
13. Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis. Bansal A; Arora A Neurourol Urodyn; 2017 Sep; 36(7):1757-1762. PubMed ID: 28101889 [TBL] [Abstract][Full Text] [Related]
14. Benign prostatic hyperplasia: mode of presentation and postoperative outcome. Khan M; Khan AL; Khan S; Nawaz H J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691 [TBL] [Abstract][Full Text] [Related]
15. Role of combined use of ketoconazole and tamsulosin in management of acute urinary retention due to benign prostatic obstruction (a randomized controlled trial). Elbendary M; El-Gamal OM; Soliman MG; Tawfik A; Taha MR Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):362-6. PubMed ID: 24018711 [TBL] [Abstract][Full Text] [Related]
16. Retrospective analysis of management of patients presenting with acute urinary retention due to benign prostatic hyperplasia: a hospital based study. Pandit RK; Agrawal CS; Chalise PR; Sapkota G Kathmandu Univ Med J (KUMJ); 2008; 6(24):448-52. PubMed ID: 19483424 [TBL] [Abstract][Full Text] [Related]
17. A prospective study of conservatively managed acute urinary retention: prostate size matters. Kumar V; Marr C; Bhuvangiri A; Irwin P BJU Int; 2000 Nov; 86(7):816-9. PubMed ID: 11069406 [TBL] [Abstract][Full Text] [Related]
18. Management of postoperative urinary retention: a randomized trial of in-out versus overnight catheterization. Lau H; Lam B ANZ J Surg; 2004 Aug; 74(8):658-61. PubMed ID: 15315566 [TBL] [Abstract][Full Text] [Related]
19. Feedback microwave thermotherapy versus TURP/prostate enucleation surgery in patients with benign prostatic hyperplasia and persistent urinary retention: a prospective, randomized, controlled, multicenter study. Schelin S; Geertsen U; Walter S; Spångberg A; Duelund-Jacobsen J; Krøyer K; Hjertberg H; Vatne V; Richthoff J; Nordling J Urology; 2006 Oct; 68(4):795-9. PubMed ID: 17070355 [TBL] [Abstract][Full Text] [Related]
20. Prospective randomized placebo-controlled study to assess the safety and efficacy of silodosin in the management of acute urinary retention. Kumar S; Tiwari DP; Ganesamoni R; Singh SK Urology; 2013 Jul; 82(1):171-5. PubMed ID: 23561712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]